Lymphocytes Rabbit Polyclonal Antibody

Specifications

Product Data
Applications	CT
Recommend Dilution	Cytotoxicity studies (See Protocols).
Reactivity	Rat
Host	Rabbit
Clonality	Polyclonal
Immunogen	Rat thymus, spleen and lymph node.
Specificity	This antibody reacts with all Rat Lymphocytes and is strongly cytotoxic.
Formulation	State: Serum State: Lyophilized Antiserum which has been adsorbed with Rat Erythrocytes and hepatocytes and filtered to 0.45μm (non-sterile).
Reconstitution Method	Restore with 1.0 ml of distilled water.
Conjugation	Unconjugated
Storage Condition	Store Lyophilized at -20°C. After reconstitution, aliquot and freeze unused portions at –70°C in volumes appropriate for single usage. Avoid repeated freeze/thaw cycles.
Note	Protocol: Protein Concentration: 271.5 +/- 16.6 mg/ml Cytotoxicity Analysis: Method: 1. Prepare a cell suspension from the appropriate tissue in Cytotoxicity Mediuma or equivalent. Remove red cells and dead cells (where necessary) by purification of viable lymphocytes on Lympholyte®-Ratb density cell separation medium. After washing, adjust the cell concentration to 1x10e6 cells per ml in Cytotoxicity Medium. 2. Add the antibody to a final concentration of 1:10 and mix. 3. Incubate for 60 minutes at 4°C. 4. Centrifuge to pellet the cells and discard the supernatant. 5. Resuspend to the original volume in Low-Tox®-Rc diluted to the recommended concentration in Cytotoxicity Medium (~1:8). 6. Incubate for 60 minutes at 37°C. 7. Place on ice. 8. Add Trypan Blue, 10% by volume of 1% Trypan Blue (w/v) added 3-5 minutes before scoring works well. Score live versus dead cells in a hemacytometer. Cytotoxic Index (C. I.) can be calculated as follows: C.I. = 100%Cyt (Ab+Complement) - %Cyt (Complement) / 100% - %Cyt (Complement). Cytotoxicity Depletion Assay: Method: 1. Prepare a cell suspension from the appropriate tissue in Cytotoxicity Mediuma or equivalent. Remove red cells and dead cells (where necessary) by purification of viable lymphocytes on Lympholyte®-Ratb density cell separation medium. After washing, adjust the cell concentration to 1x10e7 cells per ml in Cytotoxicity Medium. 2. Add the antibody to a final concentration of 1:10 and mix. Alternatively, pellet the cells and resuspend in antibody diluted 1:10 in Cytotoxicity Medium. 3. Incubate for 60 minutes at 4°C. 4. Centrifuge to pellet the cells and discard the supernatant. 5. Resuspend to the original volume in Low-Tox®-R Complementc diluted to the appropriate concentration in Cytotoxicity Medium. (Recommended concentration included with each batch of Low-Tox®-R Complement.) 6. Incubate for 60 minutes at 37°C. 7. Monitor for percent cytotoxicity before further processing. For this purpose, remove a small sample from each tube, dilute 1:10 with medium, and add 1/10 volume of 1% Trypan Blue. After 3-5 minutes, score live versus dead cells with a hemacytometer. 8. For functional studies, remove the dead cells from the treated groups before further processing, particularly if the treated cells are to be cultured. This can be done by layering the cell suspension over a separation medium and centrifuging at room temperature as per the instructions provided. Live cells will form a layer at the interface, while the dead cells pellet. The interface can then be collected and washed in Cytotoxicity Medium before being resuspended in the appropriate medium for further processing. Alternatively, the cells can be washed and resuspended in the appropriate medium for further processing immediately after Step #6, provided that the dead cells will not interfere with subsequent assays. Results: Cell Source: Thymus Donor: Buffalo Cell Concentration: 1x10e6 cells/ml Complement: Low-Tox®-R Complement Complement Concentration Used: 1:8 Procedure: Two-stage cytotoxicity as described below Tissue Distribution By Cytotoxicity Analysis: Procedure: See below Strain: Fisher Antibody Concentration Used: 1:10 Complement: Low-Tox®-R Complement Complement Concentration Used: 1:8 Cell Source: C.I.% Thymus: 100% Spleen: 79% Lymph Nodes: 87% Bone Marrow: 86% Functional Testing: Method: Cells were treated as described in Cytotoxicity Depletion Assay. Treated cells and controls were tested for: a) mitogen proliferation assay: Concanavalin A (CON A), Phytohaemagglutinin (PHA) and Lipopolysaccharide (LPS). b) the ability to generate cytotoxic T effector cells using a cytotoxic lymphocyte reaction (CTL) assay. Cells were treated both before and after sensitization in the CTL assay. In vitro immunizations were used in all experiments. Results: Cell Source: Splenocytes Donor: Rat Cell Concentration: 1x10e7 cells / ml. Antibody Concentration: 1:20 Complement: Low-Tox®-R Complement at 1:8 a) Cell depletion with AP31643SU-N was found to inhibit the CON A, PHA and LPS responses (98%, 93% and 87% respectively). b) Treatment of Rat splenocytes with AP31643SU-N plus complement essentially eliminated in vitro T effector cell function. NOTES: a. Cytotoxicity Medium is RPMI-1640 with 25 mM Hepes buffer and 0.3% bovine serum albumin (BSA). BSA is substituted for the conventionally used fetal calf serum (FCS) because we have found that many batches of FCS contain complement-dependent cytotoxins to rat and mouse lymphocytes, thus increasing the background killing in the presence of complement. Some batches of BSA also contain complement-dependent cytotoxins, resulting in the same problem. We screen for batches of BSA giving low background in the presence of complement and use the selected BSA for preparing Cytotoxicity Medium. b. Lympholyte®-Rat cell separation medium is a density separation medium designed specifically for the isolation of viable rat lymphocytes. This separation medium provides a high and non-selective recovery of viable rat lymphocytes, removing red cells and dead cells. The density of this medium is 1.0940 +/- 0.001. Isolation of rat lymphocytes on cell separation medium of density 1.077 will result in high and selective loss of lymphocytes and should be avoided. c. Low-Tox®-R complement is a highly active source of complement specifically designed for use with rat lymphocytes. When used in conjunction with Cytotoxicity Medium, this reagent provides a highly potent source of complement with minimal background cytotoxicity.
Reference Data

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.